戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ctivated by protein kinase C lambda/iota and cytosolic phospholipase A2.
2 P kinases and induces the phosphorylation of cytosolic phospholipase A2.
3 rifluoromethyl ketone, a potent inhibitor of cytosolic phospholipase A2.
4 al probes, such as lysosomal acid lipase and cytosolic phospholipase A2.
5 FP, but by inhibitors of either secretory or cytosolic phospholipase A2.
6                     Reduced Ca(2+)-dependent cytosolic phospholipase A2 activation and oxidative meta
7 cells, PDGF-induced MAPK activation leads to cytosolic phospholipase A2 activation, PGE2 release, and
8                                    Increased cytosolic phospholipase A2 activity and lyso-phosphatidy
9 included measurement of prostaglandin E2 and cytosolic phospholipase A2 activity in membrane fraction
10           We further show that MIF regulates cytosolic phospholipase A2 activity via a protein kinase
11                                              Cytosolic phospholipase A2-alpha (cPLA2-alpha) is a calc
12 ee functionally distinct signaling proteins: cytosolic phospholipase A2-alpha (cPLA2-alpha), protein
13  as novel therapeutic targets in cancer (eg, cytosolic phospholipase A2, an upstream target of the cy
14 ression of key enzymes in NPD1 biosynthesis, cytosolic phospholipase A2 and 15-lipoxygenase, was alte
15 Similarly, PGF2alpha causes translocation of cytosolic phospholipase A2 and also results in a 7-fold
16     Enhancement was blocked by inhibitors of cytosolic phospholipase A2 and cytochrome P450 epoxygena
17 arachidonic acid from phospholipid stores by cytosolic phospholipase A2 and cytochrome P450 metabolis
18  which is due to a constitutively stimulated cytosolic phospholipase A2 and enhanced basal expression
19 osphorylation and activation of the Group IV cytosolic phospholipase A2 and of the extracellular-sign
20 ll as beta-arrestin1-dependent activation of cytosolic phospholipase A2 and release of arachidonate,
21 age-dependent alpha1G subtype Ca2+ channels, cytosolic phospholipase A2, and epoxyeicosatrienoic acid
22 ETE from membrane phospholipids by group IVA cytosolic phospholipase A2, and its conversion to bioact
23 l proliferation; to induce the activation of cytosolic phospholipase A2; and to inhibit Na+-K+-ATPase
24 ar relevance to studies on the regulation of cytosolic phospholipase A2 as these two MAPKs are capabl
25 d the binding of beta-arrestin1 to activated cytosolic phospholipase A2 as well as beta-arrestin1-dep
26  phosphorylation of Raf1, MEK1, p42mapk, and cytosolic phospholipase A2, as well as the associated in
27 es upon cell stimulation, and cooperate with cytosolic phospholipase A2 at the membrane surface to ge
28                       AAOCF3, which inhibits cytosolic phospholipase A2, blocked thapsigargin-stimula
29                             The C2 domain of cytosolic phospholipase A2 (C2cPLA2) plays an important
30 ether the RvD1 biosynthetic machinery (e.g., cytosolic phospholipase A2, calcium-independent phosphol
31 utamate signaling through the NMDA receptor, cytosolic phospholipase A2, COX-2, and mPGES-1 increases
32 re stretched, the peripheral membrane enzyme cytosolic phospholipase A2 (cPLA(2)) binds via its calci
33                                              Cytosolic phospholipase A2 (cPLA(2)) controls some of th
34  F. tularensis-infected macrophages requires cytosolic phospholipase A2 (cPLA(2)), cyclooxygenase 2 (
35 a novel, activation state-dependent role for cytosolic phospholipase-A2 (cPLA(2)) in myelin-mediated
36 ive of this study was to investigate whether cytosolic phospholipase A2 (cPLA2 ), an important isofor
37  high levels of MYC, we found an increase in cytosolic phospholipase A2 (cPLA2) activity with a prefe
38 on specifically inhibited receptor-dependent cytosolic phospholipase A2 (cPLA2) activity, whereas thi
39 on in VWF/GPIb-IX-induced phosphorylation of cytosolic phospholipase A2 (cPLA2) and consequent thromb
40 cells have constitutively high expression of cytosolic phospholipase A2 (cPLA2) and cyclooxygenase (C
41  by constitutively high expression of 85-kDa cytosolic phospholipase A2 (cPLA2) and cyclooxygenase 2
42                 In contrast, the kinetics of cytosolic phospholipase A2 (cPLA2) and extracellular sig
43 ing findings exist regarding the function of cytosolic phospholipase A2 (cPLA2) and its role in membr
44  rapidly activates the enzymatic activity of cytosolic phospholipase A2 (cPLA2) as at-tested to by ar
45  NE enhanced release of AA via activation of cytosolic phospholipase A2 (cPLA2) but not secretory PLA
46                                              Cytosolic phospholipase A2 (cPLA2) catalyzes release of
47        The 85-kDa Group IV calcium-dependent cytosolic phospholipase A2 (cPLA2) catalyzes the hydroly
48                                              Cytosolic phospholipase A2 (cPLA2) catalyzes the selecti
49                                              Cytosolic phospholipase A2 (cPLA2) catalyzes the selecti
50       This study demonstrates that host cell cytosolic phospholipase A2 (cPLA2) contributes to E. col
51                                              Cytosolic phospholipase A2 (cPLA2) controls AA generatio
52                      We examined the role of cytosolic phospholipase A2 (cPLA2) during human eosinoph
53                                 The group IV cytosolic phospholipase A2 (cPLA2) exhibits a potent and
54 ase-1 (COX-1), cyclooxygenase-2 (COX-2), and cytosolic phospholipase A2 (cPLA2) expression, the rate-
55                                              Cytosolic phospholipase A2 (cPLA2) frees arachidonic aci
56      We have used mice in which the gene for cytosolic phospholipase A2 (cPLA2) has been disrupted to
57                                    Group IVA cytosolic phospholipase A2 (cPLA2) has been shown to pla
58                                              Cytosolic phospholipase A2 (cPLA2) hydrolyzes the sn-2-a
59 port we examine the phosphorylation state of cytosolic phospholipase A2 (cPLA2) in C3HA fibroblasts t
60 be due to the relatively lower expression of cytosolic phospholipase A2 (cPLA2) in H596 cells than th
61 fies the phosphorylation sites of the 85-kDa cytosolic phospholipase A2 (cPLA2) in human platelets an
62  mediating phosphorylation and activation of cytosolic phospholipase A2 (cPLA2) in intact cells remai
63 rol expression of the arachidonyl-selective, cytosolic phospholipase A2 (cPLA2) in intestinal cells.
64                   To investigate the role of cytosolic phospholipase A2 (cPLA2) in regulating the dif
65                                  The role of cytosolic phospholipase A2 (cPLA2) in the regulation of
66                                  Utilizing a cytosolic phospholipase A2 (cPLA2) inhibitor, we show th
67                                              Cytosolic phospholipase A2 (cPLA2) is a Ca2+-dependent e
68 dependent lipid binding domain of the 85-kDa cytosolic phospholipase A2 (cPLA2) is a homolog of C2 do
69                We have shown previously that cytosolic phospholipase A2 (cPLA2) is able to activate g
70                             The C2 domain of cytosolic phospholipase A2 (cPLA2) is involved in the Ca
71  have reported recently that the activity of cytosolic phospholipase A2 (cPLA2) is necessary for the
72                    The Ca2+-sensitive 85-kDa cytosolic phospholipase A2 (cPLA2) is responsible for th
73                 TNF activation of the 85-kDa cytosolic phospholipase A2 (cPLA2) is thought to be esse
74 erest to know whether arachidonate-releasing cytosolic phospholipase A2 (cPLA2) localizes at lipid bo
75                                              Cytosolic phospholipase A2 (cPLA2) mediates agonist-indu
76 yotic signal-transducing proteins, including cytosolic phospholipase A2 (cPLA2) of the vertebrate inf
77                   No changes in the level of cytosolic phospholipase A2 (cPLA2) or COX-1 were observe
78 GF, but not IGF-I, stimulated MAPK activity, cytosolic phospholipase A2 (cPLA2) phosphorylation, and
79              Our previous work suggests that cytosolic phospholipase A2 (cPLA2) plays a role in the p
80 ticularly the potential contributions of the cytosolic phospholipase A2 (cPLA2) signaling pathway.
81                             Translocation of cytosolic phospholipase A2 (cPLA2) to Golgi and ER in re
82                                  Full-length cytosolic phospholipase A2 (cPLA2) was cloned from U937
83 AA) release and on protein levels of p11 and cytosolic phospholipase A2 (cPLA2) was studied in two ep
84 thway (Ras/Raf/MEK/ERK) and Ca(2+)-dependent cytosolic phospholipase A2 (cPLA2) were activated in chl
85 e phosphorylation sites on the human, 85-kDa cytosolic phospholipase A2 (cPLA2) were identified using
86 triggers the interaction of the C2 domain in cytosolic phospholipase A2 (cPLA2) with the CARD domain
87 e gel electrophoresis immunoblot signals for cytosolic phospholipase A2 (cPLA2), 5-lipoxygenase (5-LO
88                                 Knockdown of cytosolic phospholipase A2 (cPLA2), a key enzyme for gen
89 e, both basal and IL-1-induced expression of cytosolic phospholipase A2 (cPLA2), a key enzyme-regulat
90 on increased phosphorylation and activity of cytosolic phospholipase A2 (cPLA2), an enzyme causing AA
91 g (1) inhibition of nuclear translocation of cytosolic phospholipase A2 (cPLA2), and (2) blockade of
92 rylation of ERKs, whereas phosphorylation of cytosolic phospholipase A2 (cPLA2), and arachidonic acid
93 (Ad5) affects the expression and activity of cytosolic phospholipase A2 (cPLA2), cyclooxygenase-2 (CO
94                      Tissue damage activates cytosolic phospholipase A2 (cPLA2), releasing arachidoni
95 glutamate released during seizures activates cytosolic phospholipase A2 (cPLA2), resulting in P-gp an
96  mitogen-activated protein kinase (MAPK) and cytosolic phospholipase A2 (cPLA2), resulting in release
97 quires protease-activated receptors 1 and 4, cytosolic phospholipase A2 (cPLA2), Src tyrosine kinases
98 ism of calcium-dependent membrane binding of cytosolic phospholipase A2 (cPLA2), we measured the inte
99 ed protein (MAP) kinase in the regulation of cytosolic phospholipase A2 (cPLA2)-mediated AA release b
100 , zymosan, and correlates with activation of cytosolic phospholipase A2 (cPLA2).
101 ghly dependent on previous activation of the cytosolic phospholipase A2 (cPLA2).
102 racts with the carboxyl region of the 85-kDa cytosolic phospholipase A2 (cPLA2).
103 ught to require TNF-activation of the 85-kDa cytosolic phospholipase A2 (cPLA2).
104  mitogen-activated protein kinase (MAPK) and cytosolic phospholipase A2 (cPLA2).
105 pha caused phosphorylation and activation of cytosolic phospholipase A2 (cPLA2).
106 nic acid (AA) from membrane phospholipids by cytosolic phospholipase A2 (cPLA2).
107 ndent signal involves activation of group IV cytosolic phospholipase A2 (cPLA2).
108 ed human cDNAs encode paralogs of the 85-kDa cytosolic phospholipase A2 (cPLA2).
109                  Lysolecithin also activated cytosolic phospholipase A2 (cPLA2).
110 rachidonic acid by phospholipase A2, and the cytosolic phospholipase A2 (cPLA2)alpha isoform has been
111 ular dynamics simulation of the C2 domain of cytosolic phospholipase A2 (cPLA2-C2) in a 1-palmitoyl-2
112  amino-terminal, 138 amino acid C2 domain of cytosolic phospholipase A2 (cPLA2-C2) mediates an initia
113 pholipase A2 (sPLA2) amplifies the action of cytosolic phospholipase A2(cPLA2) alpha in regulating ei
114                        The role of Group IVA cytosolic phospholipase A2 (cPLA2alpha) activation in re
115                                    Group IVA cytosolic phospholipase A2 (cPLA2alpha) acts as a bridge
116 sion was shown to require activation of host cytosolic phospholipase A2 (cPLA2alpha) by Loops1 and 2
117  There is compelling evidence that group IVA cytosolic phospholipase A2 (cPLA2alpha) targets arachido
118 ygous loss-of-function mutation in group IVA cytosolic phospholipase A2 (cPLA2alpha).
119  macrophages through activation of group IVA cytosolic phospholipase A2 (cPLA2alpha).
120 itoneal macrophages, activation of group IVA cytosolic phospholipase A2(cPLA2alpha) by calcium- and m
121 ptotagmin I (SytIC2A) and the C2 domain from cytosolic phospholipase A2 (cPLA2C2) are among the best
122                                              Cytosolic phospholipases A2 (cPLA2s) consist of a family
123 staglandin E2 (PGE2) via a calcium-dependent cytosolic phospholipase A2/cyclooxygenase-mediated mecha
124 iglyceride and free fatty acid content and a cytosolic phospholipase A2-dependent increase in formati
125 tracellular Ca2+ concentration and activates cytosolic phospholipase A2, followed by lipoxygenase-cat
126 s NF-kappaBp50/p105, IL-1beta precursor, and cytosolic phospholipase A2 genes.
127                                The Group IVA cytosolic phospholipase A2 (GIVA cPLA2) is a key provide
128                                              Cytosolic phospholipase A2 (GIVA cPLA2) is the only PLA2
129                                    Group IVA cytosolic phospholipase A2 (GIVA cPLA2) is the rate-limi
130                Eicosanoids, derived from the cytosolic phospholipase A2 group IVA (cPLA2alpha) activa
131 ed that an A-->G variant (rs12746200) of the cytosolic phospholipase A2 group IVA gene (PLA2G4A), whi
132 xercised in using AACOCF3 as an inhibitor of cytosolic phospholipase A2 in whole cell assays because
133 Pretreatment of DARas with antioxidants or a cytosolic phospholipase A2 inhibitor also restores the w
134                 We also demonstrate that the cytosolic phospholipase A2 inhibitor arachidonyl trifluo
135                      In contrast, a specific cytosolic phospholipase A2 inhibitor blocked the oxidant
136 determine the effects of a putative specific cytosolic phospholipase A2 inhibitor, arachidonyl triflu
137                       Cells treated with the cytosolic phospholipase A2 inhibitor, cPLA2alpha, had no
138 d (AA) by exposure to fatty acid-free BSA or cytosolic phospholipase A2 inhibitors.
139                                              Cytosolic phospholipase A2 initiates the biosynthesis of
140                                              Cytosolic phospholipase A2 is a key regulator of blood-b
141                                              Cytosolic phospholipase A2 is involved in several signal
142 g down keratin disulfide bonds, it activated cytosolic phospholipase A2, leading to activation of the
143 g down keratin disulfide bonds, it activated cytosolic phospholipase A2, leading to activation of the
144 ion of this Ras-MAP kinase pathway activated cytosolic phospholipase A2, leading to the release of ar
145 cells that express tau, receptors coupled to cytosolic phospholipase A2 may activate PLC-gamma isozym
146                     Finally, we propose that cytosolic phospholipase A2 may be a potential source of
147  arthritis correlated with altered COX-2 and cytosolic phospholipase A2 messenger RNA levels in the j
148                       Finally, inhibition of cytosolic phospholipase A2, one of the key enzymes invol
149 alpha preferentially activates the MEK-Erk2- cytosolic phospholipase A2 pathway.
150 ntly, E-FABP deletion by CRISPR-Cas9 reduced cytosolic phospholipase A2/peroxisome proliferator-activ
151 ntly, E-FABP deletion by CRISPR-Cas9 reduced cytosolic phospholipase A2/peroxisome proliferator-activ
152 ed extracellular signal-regulated kinase and cytosolic phospholipase A2 phosphorylation, consistent w
153            Phosphorylation and activation of cytosolic phospholipase A2 (PLA2) can occur independentl
154 achidonic acid by the ubiquitously expressed cytosolic phospholipase A2 (PLA2) has a fundamental role
155 function we demonstrated increased levels of cytosolic phospholipase A2 protein and related lipid med
156  the Ca2+-dependent lipid-binding domains of cytosolic phospholipase A2, protein kinase C, Rabphilin-
157 utocrine loop by which LPI is synthesized by cytosolic phospholipase A2, pumped out of the cell by th
158                       Further, inhibition of cytosolic phospholipase A2 reduced injury and inflammati
159 activation were observed, whereas ERK1/2 and cytosolic phospholipase A2 (S505) phosphorylation was no
160                                Secretory and cytosolic phospholipases A2 (sPLA2 and cPLA2) may contri
161 ein's ability to induce prostaglandin E2 and cytosolic phospholipase A2 synthesis in patients' fibrob
162 noid synthesis proximal to the activation of cytosolic phospholipase A2, the initial rate-limiting st
163 ese two MAPKs are capable of phosphorylating cytosolic phospholipase A2, thereby increasing its intri
164                                              Cytosolic phospholipase A2 translocates from the cytopla
165 decrease in expression of MEK1, p42mapk, and cytosolic phospholipase A2, which may contribute further
166 (2+)- and kinase-dependent activation of the cytosolic phospholipase A2, which releases arachidonic a
167 ssion of cyclooxygenase-2 and phosphorylated cytosolic phospholipase A2, which was reflected in prost

 
Page Top